(although often only temporarily so) use of high-frequency ventilation (HFV) in desperate clinical situations has led to an upsurge in interest both among physiologists and clinicians in this new mode of mechanical ventilation. This dual approach has led to an enormous amount of literature being produced in a relatively short period of time, much of which has been confusing and contradictory.
High-frequency oscillation (HFO) was chosen by the physiologists for their evaluation of HFV. Their interest was centred in three main areas: mechanisms of gas exchange, nonventilatory physiological effects and the efficiency of gas exchange compared with conventional mechanical ventilation (CMV). High-frequency positive-pressure ventilation (HFPPV) and high-frequency jet ventilation (HF JV) were chosen by the clinicians for their evaluation of the technique. This was probably related to their relative ease of use and the commercial availability of delivery devices. These studies have identified conditions which may benefit from HFV as well as the complications which may follow its use.
HISTORY
The concept of maintaining pulmonary gas exchange at high ventilatory frequencies is not new. Almost twenty years ago, both Emerson and Bird, pioneers in the field of mechanical ventilation, independently designed devices capable of high-frequency, low-volume positive-pressure ventilation. These devices were so far ahead of their time that little use was made of them until they were rediscovered in the 1980s.
In 1967 in Sweden, Ob erg and Sjostrand, while investigating the carotid sinus reflex, were plagued by blood pressure fluctuations caused by changes in intrathoracic pressure related to the respiratory cycle. To minimise these pressure swings they developed a new ventilatory technique operating at 60-100 cycles per minute, termed HFPPV. 4 Lunkenheimer in Germany in 1972, while studying the effects of pericardial pressure oscillations on cardiac performance, noted that apnoea was produced by the application of transtracheal pressure vibrations in dogs 5 and that adequate oxygenation and carbon dioxide elimination could be maintained for long periods. This was the original work utilising a form of HFO. The technique lay almost unnoticed until 1980 when Bohn 6 and coworkers reconfirmed that it could provide adequate pulmonary gas exchange.
HFJV developed mainly in the U.S.A. from work by Klain and Smith 7 in 1977 using a modified Sanders jet injector technique. S Although the classification of HFV devices is still somewhat confused, the three methods just described are the three basic modes of highfrequency ventilation available today. Highfrequency flow interruption (HFFI) using the Emerson rotating ball device has been over the years variously described as an HFO, a HFJV or a HFPPV device, but has now emerged into a category of its own. Recently combined highfrequency ventilation (CHFV), high-frequency chest wall oscillation (HFCWO) and high frequency body surface oscillation (HFBSO) have been added. The classification of HFV devices is discussed fully elsewhere in this symposium.
HFV TECHNIQUES

High-Frequency Positive-Pressure Ventilation
HFPPV uses either modified conventional mechanical ventilators 9 or specifically designed low compliance systems lO to deliver small volumes at frequencies of 1 to 2 Hz. The cycling device is usually a timed solenoid valve or a mechanically driven rotating valve that is used as a flow generator to effect inspiration by delivering a full tidal volume via an endotracheal tube or tracheal catheter ( Figure  1 ). Gas entrainment is not a feature of this technique and exhalation is passive. Depending upon the circuitry used positive end-expiratory pressure (PEEP) may be applied and if an exhalation valve is used truly volume-controlled HFPPV may be delivered. The duration of inspiration is usually between 15-35070 II of the respiratory cycle and tidal volume is in the order of 2.5 to 3.5 mllkg. FIGURE I.-Schematic diagram of a HFPPV device. Blended driving gas is passed through a humidifier placed either before or after the cycling device. The cycling device is usually a time-cycled pressure-limited flow generator. The tidal volume is delivered via an endotracheal tube or tracheal catheter. An exhalation valve may be used. Air entrainment is not present. PEEP may be added by applying a force to the exhalation valve. The system may look very similar to that used for CMV, but attention has been paid to reducing the compressible volume of the system to a minimum.
HFPPV
Humidification may be achieved either by the primary gas stream directly or as humidified gas added to the primary gas stream at a fixed rate. Commercial devices for the delivery of HFPPV are available. Independent controls for rate, tidal volume, pressure limit and sometimes I:E ratio are usually present.
HFPPV was initially used for laryngoscopy, bronchoscopyI2 and tracheal surgery; 13-14 it has also been used for general surgery, 15 thoracic surgery,16 cardiac surgery, 17 and also in the neonatapS,19 and adult intensive care areas. 20 ,21
High-Frequency Jet Ventilation
HFJV is probably the most widely used form of HFV today. Intermittently, gas from a highpressure source (driving pressure) is passed through a small-bore catheter positioned in the airway (Figure 2 ), Exhalation is passive and PEEP may be added. Gas entrainment caused Anaesthesia and lnrensil'e Core, Vol. 14, No. 3, August, 1986 by venturi effects in the proximal airway is common but not invariable. Driving pressure, frequency and I:E ratio are usually adjustable. A variety of cycling mechanisms have been utilised including fluidic systems and electronically operated solenoid valves. The components of a HF JV device and their function have been well described by Carlon.22 HFJV TIME CYCLED MAP CONTROL FIGURE 2.-Schematic diagram of a HF JV device. Blended gas is passed either into the HF JV device via a pressure regulator controlling driving pressure, or through a flow meter into the patient breathing circuit. The HFJV device is a time-cycled flow generator, sending a high-pressure jet into the airway via a small bore tube. Humidification is achieved by a continuous water or saline feed into the highpressure jet stream. Additional humidification may be obtained from fully humidified gas entrained from the patient breathing circuit. A valve may be added to exhalation pathway of the breathing circuit to alter the level of PEEP or mean airway pressure (MAP).
Ventilatory frequency usually ranges from 2 to 10 Hz and tidal volume from 1.0 to 2.5 mllkg. Tidal volume is dependent upon the driving pressure, the dimensions and arrangement of the connecting tubes, injector cannula size, I:E ratio and the nature of gas entrainment2 3 as well as the impedance of the respiratory system. Mean airway pressure is dependent upon driving pressure, I:E ratio and the level of PEEP, if any, that is added to the patient's breathing circuit.
Humidification may be achieved by placing a humidifier before or after the cycling device, or more commonly by the continuous instillation of saline or water into the driving gas stream. Additional humidification may be gained by gas entrainment from the patient's breathing circuit,22 but this should not be relied upon. 
High-Frequency Oscillation
HFO utilises a reciprocating mechanism, usually a piston pump,6 a diaphragm 5 or loudspeaker 31 to produce oscillatory gas flows within the airway ( Figure 3 ). These gas flows need not be sinusoidal, but, however, have clearly defined active inspiratory and expiratory phases. A steady fresh gas flow (bias flow) is delivered to the proximal airway in order to provide a supply of oxygen and a means of carbon dioxide removal. Gas leaves the system, usually through a low-pass filter, a long narrow tube that provides a high impedance to gas with a high oscillatory frequency but only a low impedance to gas with a low frequency. The system has no valves and mean airway pressure may be controlled either by altering the fresh gas flow 6 or altering the back pressure produced by the low pass filter. 32
LOW PASS FILTER FIGURE 3.-Schematic diagram of a HFO device. Blended gas is passed through a flowmeter, a humidifier and then into the HFO circuit. The HFO pump, usually a piston pump, actively pushes gas into the airway then actively sucks it out again. Waste gas leaves the system through a low-pass filter, which provides a low impedance to gas with a low oscillatory frequency and a high impedance to gas with a high oscillatory frequency. Mean airway pressure may either be controlled with a device on the low-pass filter or by altering the bias flow.
Ventilatory frequencies usually range between [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] Hz, although frequencies up to 50 Hz have been reported. Tidal volume is in the order of 0.8 to 2 mllkg. Most oscillators have a variable stroke volume. Some have a fixed stroke with a variable compliance in parallel with the patient's lungs. Some have adjustable c I:E ratios, but most are fixed at 1: 1. The delivered tidal volume depends upon the pump stroke volume, compressible circuit volume, size of the endotracheal tube 33 ,34 compared with the low-pass filter, resonant amplification (if any) of the stroke volume within the breathing circuit 35 and the impedance of the respiratory system. Humidification is easily achieved by humidifying the total fresh gas flow prior to entry into the breathing circuit.
HFO has been used as a research tool to study mechanisms of gas transport, gas exchange and other non-respiratory aspects of lung function during HFV. It has been used in the operating room for general, orthopaedic 32 and thoracic surgical procedures. 36 As well it has been used with some success in the treatment of neonates with RDS. 34 
High-Frequency Flow Interruption
HFFI ( Figure 4 ) delivers gas to the patient's lungs from a pressurised source (driving pressure), through a pneumatic or electronic valve arrangement. The pulsatile flow is placed some distance from the patient's airway. In some devices a source of bias flow is required to magnify the delivered tidal volumeY Exhalation is passive either through a low-pass filter or an exhalation valve. Mean airway pressure can usually be altered by modifications to the low-pass filter, exhalation valve or bias flow. Ventilatory frequency can with some devices be varied to encompass the whole spectrum of frequencies and thus tidal volumes used with HFV. The I:E ratio in some devices can be altered, but in others such as the Emerson rotating ball it is fixed such that inspiration occupies 30070 of the respiratory cycles.
Tidal volume is dependant upon driving pressures,38 inspiratory time, gas compression within the circuit,37 amplification of the flow signal and the impedance of the inspiratory system relative to the low pass filter. Humidification is achieved by placing a humidifier prior to the cycling mechanism 38 or alternatively a bias flow of fully humidified gas may be added to the primary gas stream following the cycling mechanism. 37 HFFI ROTATING BALL FIGURE 4.-Schematic diagram of a HFFI device. Blended gas is passed either through a flowmeter into the HFFI device or through another flowmeter into a humidifier, then added to the patient circuit as a bias flow for amplification of the flow signal. The driving gas is passed through the HFFI device which is usually a time-cycled flow generator. The cycling device is placed some distance from the airway, If no bias flow is present the driving gas stream will need to be humidified. Waste gas leaves the system usually through a low-pass filter similar to HFO. High-frequency chest wall oscillation (HFCWO) applies rapid compressions to the chest wall. 44 Endotracheal intubation is not required and lung volume is maintained slightly below FRC thus limiting its use in the treatment of acute respiratory failure. High-frequency body surface oscillation (HFBSO) applies external oscillations to the entire body surface. 45 It requires the placement of the subject in a closed chamber with the trachea opened to atmosphere usually with an endotracheal tube thus rendering it an unsuitable technique for use in an intensive care unit.
MECHANISMS OF GAS TRANSPORT The mechanisms responsible for maintaining adequate gas exchange with tidal volumes less than the measured anatomical dead space have been extensively studied 46 -58 and well reviewed 59-61 and although still not fully understood, a clearer picture is emerging ( Figure 5 ). Most studies cited in this discussion refer to HFO. However, it seems likely that these mechanisms of gas transport also apply to HFJV. 
MECHANISMS OF GAS TRANSPORT DURING HFV
Convective mechanisms of gas transport
Direct alveolar ventilation is by far the most efficient mode of gas transport during HFV and may well be one of the major mechanisms. ROSS 62 in 1957 suggested that the asymmetry existing in the human bronchial tree could lead to shorter transit times of gas transport between certain alveoli and the mouth. Rehder 54 demonstrated faster gas turnover rates in apical nondependent regions using HFV in man. This may reflect that the apical alveoli have shorter pathway lengths for convective gas transport than the other lung regions, or it may be that their airway geometry allows for preferential ventilation with low tidal volumes. Isabey, 63 using a physical model representing the branching airways, has shown that with oscillatory laminar flow, complete washout of the anatomical dead space prior to obtaining alveolar ventilation is not needed. 'Alveolar ventilation' through the core of his conduit could easily be maintained with tidal volumes as low as 80070 of the measured dead space of the system. Many investigators of HFO use stroke volumes of 0.5 to 0.75 of the measured anatomical dead space in order to produce normocarbia. Once tidal volume is reduced below this level there is a marked deterioration or cessation of gas transport. 49,51,56 Crawford and Rehder (unpublished data) using an ultrasonic flowmeter 64 with an adequate frequency response 35 have found that the mean tidal volume requirement in ten anaesthetised patients using HFO was 0.99 mllkg at a frequency of 12 Hz. Since anatomical dead space in man is in the order of 2.2 mllkg,66 but is reduced to the order of 1.1 mllkg following endotracheal intubation, 67 tidal volumes greater than this may allow for some direct alveolar ventilation. Allowing for wide variations in pathway lengths to various alveoli and the possibility of ventilation through the core of the conducting airways, direct alveolar ventilation of a substantial proportion of the lung may occur with tidal volumes less than the measured anatomical dead space and probably still occurs at frequencies as high as 12 Hz in man.
During a rapid inspiration, fresh gas will initially be delivered to a lung region with a short time constant. This region will subsequently empty into a lung region with a longer time constant. During expiration, the reverse will occur with the region with the short time constant emptying into the conducting airways and subsequently being partially filled with gas from the region with the slow time constant. The convective transport of gas out of phase with the primary HFO is called pendelluft and may not only occur between alveoli but also between conducting airways and alveoli. That marked pendelluft occurs during HFO has been clearly shown 48 ,50 but its importance in gas transport is still unknown, and its major effect is its tendency to homogenise the gas concentrations throughout the lung. Pendelluft of course also occurs with CMV, however on a much smaller scale.
Convective gas transport can also occur due to asymmetric velocity profiles. Inspiratory profiles around bronchial bifurcations are peaked and expiratory profiles more flattened, resulting in oxygen-rich gas being transported distally through the centre of the airway and carbon dioxide-rich gas being transported proximally at the perimeter of the airway. Haselton and Scherer 68 used this to propose a purely convective longitudinal gas transport mechanism to occur with high frequency oscillatory flows. Although it occurs with HFV, as with CMV, its overall contribution to gas exchange is probably minor.
Dispersive gas transport mechanisms
These mechanisms of gas transport are the result of secondary mixing set up by the primary axial transport mechanism, the delivered tidal volume and can be subdivided into Taylor type, oscillatory and branching types.
Since Taylor was the first to describe dispersion of material in a conduit due to the interaction of the axial velocity profile and the radial concentration gradient, some of these mechanisms are often referred to as Taylortype dispersive mechanisms. 68, 69 Taylor turbulent dispersion occurs with HFV in the upper airways, virtually abolishing radial concentration gradients. Taylor laminar dispersion occurs more distally with radial concentration gradients maintained, allowing for ventilation through the core of the airway.
With HFO, flow changes direction twice every cycle and thus inertia of the medium becomes very important. Molecules moving with a certain axial velocity are resistant to reversing their direction and will continue to travel for some time out of phase with the applied pressure changes.
Dispersion also occurs in branching airways due to asymmetric velocity profiles occurring at bifurcations as well as secondary flow eddies occurring at these points. These dispersive mechanisms of gas transport also occur with CMV but are not as marked as with HFV.
Molecular diffusion
During HFO as with CMV the axial gas velocities in the lung periphery are probably very low. The final transport mechanism for 02 and C02 near the alveolocapillary membrane in both cases is likely to be molecular diffusion. That this mechanism of gas transport is not the rate limiting step of gas exchange during HFO has been shown. 47 ,70 Collateral ventilation between alveolar lung units occurs with HFV as with CMV, but it is not as pronouncedY
Overall gas transport with HFV
Most studies utilising HFV have shown that when proper tidal volumes and frequencies are used all types of HFV will maintain adequate transport of oxygen and carbon dioxide. Initial predictions 71 and studies 53, 56 suggested that tidal volume and frequency were of equal importance. It is now, however, accepted that tidal volume is of greater importance. 49 ,51,55,72-76 Jaeger 74 and Weinmann 75 have found the overall gas transport coefficient in dogs with HFV to be proportional to the square of the tidal volume multiplied by the frequency of delivery. This corresponds closely to the theoretical predictions by Permutt. 77 Crawford and Rehder (unpublished data) have found that in order to maintain normocarbia in anaesthetised man with HFO, tidal volume requirements at 3, 5 and 12 Hz are 1.95 mllkg, 1.52 mllkg and 0.99 mllkg respectively. This suggests that in man with HFV up to 12 Hz the overall gas transport coefficient (D lung) is proportional to frequency multiplied by the square of the tidal volume.
Thus a hundredfold increase in frequency allows only a tenfold reduction in tidal volume, resulting in a marked increase in minute volume as ventilatory frequency is increased. It is of interest to note that this formula would predict a tidal volume requirement of just over 8 mllkg with CMV at a frequency of 10 breaths/min in these patients.
Although the overall gas transport coefficient of the lung at the lower frequencies seems related linearly to frequency and to the square of the tidal volume this may not be so at extremely high frequencies. 76 The concepts of optimal 6 and limiting 51 ,52 oscillatory frequency have appeared oocasionally in the literature. Using HFO, at a fixed stroke volume, maximum delivered tidal volume will occur at the resonant frequency of the breathing circuit. 35 This mechanism may account for earlier reports of optimal frequencies with HFV. For a given delivered tidal volume, maximum CO 2 clearance should occur at the resonant frequency of the lung. In anaesthetised man no optimal frequency has been found between 3-12 HzY In normal dogs 56 and monkeys73 but not in rabbits,n increasing ventilatory frequency causes a linear increase in CO 2 removal. Dogs, when given histamine infusions,52 develop a frequency limitation in CO 2 elimination. Further increases in ventilatory frequency will not result in corresponding increases in C02 removal. A similar result was found by Rossing 51 in six patients with chronic respiratory failure where C02 elimination was linear only to frequencies ranging from 180 to 360/min. These investigators have postulated that at higher frequencies under these circumstances the central airways may behave as a 'shunt compliance' having a relatively fast time constant in relationship to the peripheral airways.51,52,58 Much of the tidal volume is thus lost, producing marked volume changes within the central airways instead of penetrating into peripheral lung units.
In patients with chronic obstructive lung disease undergoing thoracotomy procedures, expansion and collapse of the trachea and major bronchi in phase with the applied HFO has been seen. 36 The mechanism for this phenomenon is likely to be expiratory flow limitation, and could have been predicted to occur in these patients at the high gas flows and low mean airway pressures used. Although a frequency limitation of CO 2 removal may be seen in patients with obstructive lung disease, adequate pulmonary ventilation has been maintained in anaesthetised man for up to several hours at frequencies as high as 18 HzY 
GAS EXCHANGE WITH HFV
It is now clear that HFV even in the long term will maintain gas exchange equivalent to CMV in normaP2,48,54,78 and abnormal lungs 2o ,25,80-85 provided lung volumes are equivalent. This is usually accomplished at a lower peak airway pressure. There is no evidence to show that HFV is superior to CMV in providing gas exchange in the face of a right-to-left intrapulmonary shunt or ventilation-perfusion mismatch.
The initial dramatic success with the use of HFV was in the treatment of bronchopleural fistulae. 26 -28 It was thought, and a mathematical model was developed to explain,86 that at the high frequencies used the impedance of the leak is increased in such a way that the alveoli received a larger share of the delivered tidal volume. That HFV can maintain adequate alveolar ventilation in the face of a large air leak is undoubted, but it may do so only by its ability to generate such an enormous minute volume that the air leak becomes of little importance. 87 Albelda has recently shown in man that unless peak airway pressure was reduced with HFV no reduction occurred in the gas loss through a bronchopleural fistula, 88 Numerous clinical reports and personal experience would suggest that HFV is beneficial in neonates who develop pulmonary barotrauma related to CMV. 18, 29, 30, 38, 40 This is probably related to its ability to maintain alveolar ventilation at lower peak airway pressures, The results of controlled clinical studies are needed to determine whether HFV is of real benefit in this situation.
To maintain optimal gas exchange with HFO, some investigations believe that periodicsustained lung inflations to 30 or 40 cm H20 are required to expand atelectatic alveoli, similar to the 'sighs' once advocated during CMV.
AIRWAY PRESSURE AND LUNG VOLUME Mean airway pressure during HFV varies depending upon the site of measurement. 48 It is lowest at the site of maximum gas velocity, usually the endotracheal tube, and increases distally as gas velocity decreases. Many investigators are now using occlusion pressure,32,35,89-91 the static pressure within the airway following its occlusion for a few seconds. The pressure thus obtained is thought to more closely relate to mean alveolar pressure and thus lung volume.
An increase in functional residual capacity has frequently been reported with HFV. 32 ,36,48,54,90-94 This phenomenon is more pronounced in patients with chronic obstructive airways disease and appears in part to be related to expiratory flow limitation. 32, 36, 54, 90, 94 It is more common at higher frequencies and higher I:E ratios. Even though airway pressure may not always reflect alveolar pressure, a good correlation usually exists between the two variables with HF JV. 91 This may not be so with HF0 36 where an active expiratory phase may encourage proximal airway collapse with a consequent marked reduction in measured airway pressure, while still maintaining significant distal gas trapping.
Recently and biochemical analysis 82 ,83,l02 of lung tissue exposed to HFV shows no difference from lung tissue exposed to CMV. A minor change in surfactant metabolism has been seen, but it is unknown whether this is significant. 103 Rouby noted an increase in static respiratory compliance with an increase in FRC in a group of patients with postoperative respiratory failure. Since FRC increased, specific compliance probably did not change with HFV. 91 Most investigators report an abundance of respiratory tract secretions following institution of HFV. The increased flow of secretions is temporary and it is unknown whether it represents increased mobilisation or production. McEvoy noted a decrease in mucociliary transport with HFO when com pared with CMV. 104 Gross, however, has found a marked increase in the tracheal mucus clearance rate with HFCWO and has suggested that this mode of ventilation may in the future be of great benefit for respiratory physiotherapy. 105 The effect of HFV on lung lymph flow and composition is contradictory and needs clarification. 106, 107 CARDIOVASCULAR FUNCTION AND HFV One of the theoretical advantages of HFV was thought to be that at the lower airway pressures used the deleterious effects of CMV on cardiovascular function could be avoided. Although many studies have produced conflicting results there appears overall to be no significant difference in cardiac output between CMV and HFV. 20 ,25,l08-111 If cardiac performance is being compromised by mechanical ventilation HFV may be beneficiaPll but even this has been challenged. 112 Synchronising the jet pulsation to various parts of the cardiac cycle was once thought to provide circulatory assistance. 7 This has not been shown to be the case in a variety of experimental studies using healthy dogS. lll ,ll3 Even so, synchronising HFV with the cardiac events still seems interesting and needs to be examined in the failing heart.
The effect of HFV on pulmonary haemodynamics appears minimal and many studies reported no change in pulmonary artery pressure, pulmonary wedge pressure and pulmonary vascular resistance. 108,1 14,115 A minor increase in prostaglandin production with a consequent fall in pulmonary vascular resistance has been noted in new-born lambs. 116 Cerebral blood flow is unaltered by HFV l17 ,118 as is mean intracranial pressure. 119,120 However, intracranial pressure oscillations are reduced. 120,121 Blood flow to other organs such as heart, lung and kidney also appear unaltered by HFV.121 CONCLUSIONS HFV maintains gas exchange as well as CMV. The mechanisms of gas transport at the lower frequencies are probably similar to those occurring with CMV. Although it has been used safely and satisfactorily in almost every clinical situation it has not as yet been shown to offer definite advantages over CMV. Much has been said about the usefulness of HF1V during airway surgery although it has not been adequately compared with low-frequency jet ventilation in this situation. It seems clear that HFV will not correct all the deleterious aspects associated with mechanical pulmonary ventilation and in itself has introduced many more. Like many of the other advances in respiratory care over the years it does not seem to dramatically alter the outcome of patients with respiratory failure. However, like other advances it is likely to provide an important addition to our available modalities of ventilatory support especially in patients with barotrauma related to CMV. Increases in lung volume and high distal airway pressure swings at very high frequencies will cause more modest rates to be used in the future. Future mechanical ventilators are likely to provide the option for the delivery of HFV and they may even have the facility to deliver CHFV which at the moment seems promising and in need of further study.
Whatever the fate of HFV, it has created and continues to create an interest in pulmonary physiology not seen for a long time. The explosion of knowledge that has occurred due to its introduction has been extremely beneficial in our understanding of lung function. As a research tool it will be with us for many years, as a clinical tool it is as yet too early to know what its fate will be.
